BSX. Oh yes. Definitely a stretch.
I'll defer to your expertise and knowledge here, Dutch.
Still, I'm going to try to hold on to my few BSX shares.
The p/sales, p/book are at multi-year lows.
Things are very bleak for the company. I'm hoping for a pony in the pile though.
According to Yahoo, there are 28,000 employees at BSX and they are in several areas, not just the stents: "The company offers its products in three groups: Cardiovascular, Endosurgery, and Neuromodulation." (C'mon you new product development guys! Give us a blockbuster!)
To me, the question isn't where the company is now, but where it will be in three years. I don't know, but I am betting in a better position than now.
Not betting much though (-g-) |
